# Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles

> **NCT02310919** · PHASE3 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 105 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Low dose hCG plus FSH co-trigger
- **DRUG:** Standard dose of hCG

## Key facts

- **NCT ID:** NCT02310919
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2018-06-20
- **Final completion:** 2018-06-20
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2022-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02310919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02310919, "Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02310919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*